Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse (clinicaltrials.gov) - Oct 17, 2026 - P1/2 | N=76 | Recruiting | Sponsor: National Cancer Institute (NCI) | Not yet recruiting ➔ Recruiting | Initiation date: Oct 2026 ➔ Jun 2027
Enrollment open • Trial initiation date • Ganglioneuroblastoma • Neuroblastoma • Oncology • Solid Tumor
|